Thornburg Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-39,500
Closed -$11.5M 295
2015
Q3
$11.5M Sell
39,500
-15,281
-28% -$5.05M 0.07% 191
2015
Q2
$22.1M Buy
54,781
+11,620
+27% +$4.66M 0.13% 151
2015
Q1
$18.2M Sell
43,161
-2,620
-6% -$1.03M 0.1% 180
2014
Q4
$15.5M Buy
45,781
+3,005
+7% +$972K 0.08% 212
2014
Q3
$14.2M Buy
42,776
+5,429
+15% +$1.79M 0.06% 216
2014
Q2
$11.8M Buy
+37,347
New +$11.2M 0.05% 226

Other funds holding BIIB

Thornburg Investment Management's BIIB Position: Q4 2015 in Review

Thornburg Investment Management sold out of Biogen (BIIB) in Q4 2015, closing a stake of 39,500 shares — an estimated $11.5M sold.

Thornburg Investment Management first reported a position in BIIB in Q2 2014 and held it in 6 quarters. The position peaked at $22.1M in Q2 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Thornburg Investment Management reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Thornburg Investment Management sold 39,500 Biogen shares in Q4 2015, an estimated $11.5M.
  • Thornburg Investment Management first reported a position in Biogen in Q2 2014 and held it in 6 quarters.
  • Thornburg Investment Management's Biogen position peaked at $22.1M in Q2 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Thornburg Investment Management's 13F filing for Q4 2015, filed 9 Feb 2016.